Search research articles
Contact Us
Filters
Showing results (471-480 of 499) with videos related to
Page
of 50
Sort By:
Annals of Surgical Oncology
|
June 18, 2021
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Quisette P Janssen, Jacob L van Dam, Isabelle G Kivits, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 13, 2022
One-year performance of biorestorative polymeric coronary bypass grafts in an ovine model: correlation between early biomechanics and late serial Quantitative Flow Ratio
Xinlei Wu, Masafumi Ono, Eric K W Poon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
Quisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Annals of Surgical Oncology
|
February 5, 2025
Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
Esther N Dekker, Quisette P Janssen, Jacob L van Dam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2023
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma
Brett L Ecker, Alice J Tao, Quisette P Janssen, et al.
Annals of Surgical Oncology
|
April 1, 2025
ASO Visual Abstract: Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
Esther N Dekker, Quisette P Janssen, Jacob L van Dam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study
Esther N Dekker, Jacob L van Dam, Quisette P Janssen, et al.
The Oncologist
|
September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study
Floris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
The European Respiratory Journal
|
July 26, 2024
ERS statement on benign pleural effusions in adults
Anand Sundaralingam, Elzbieta M Grabczak, Patrizia Burra, et al.
Frontiers in Immunology
|
September 12, 2022
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
Fleur van der Sijde, Willem A Dik, Dana A M Mustafa, et al.
Page
of 50
Search research articles
Search
Showing results (471-480 of 499) with videos related to
Sort By:
Page
of 50
Annals of Surgical Oncology
|
June 18, 2021
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
Quisette P Janssen, Jacob L van Dam, Isabelle G Kivits, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 13, 2022
One-year performance of biorestorative polymeric coronary bypass grafts in an ovine model: correlation between early biomechanics and late serial Quantitative Flow Ratio
Xinlei Wu, Masafumi Ono, Eric K W Poon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
Quisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Annals of Surgical Oncology
|
February 5, 2025
Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
Esther N Dekker, Quisette P Janssen, Jacob L van Dam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2023
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma
Brett L Ecker, Alice J Tao, Quisette P Janssen, et al.
Annals of Surgical Oncology
|
April 1, 2025
ASO Visual Abstract: Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
Esther N Dekker, Quisette P Janssen, Jacob L van Dam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study
Esther N Dekker, Jacob L van Dam, Quisette P Janssen, et al.
The Oncologist
|
September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study
Floris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
The European Respiratory Journal
|
July 26, 2024
ERS statement on benign pleural effusions in adults
Anand Sundaralingam, Elzbieta M Grabczak, Patrizia Burra, et al.
Frontiers in Immunology
|
September 12, 2022
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
Fleur van der Sijde, Willem A Dik, Dana A M Mustafa, et al.
Page
of 50